Please login to the form below

Not currently logged in
Email:
Password:

Newron Pharma

This page shows the latest Newron Pharma news and features for those working in and with pharma, biotech and healthcare.

Newron back on track for Xadago approval in US

Newron back on track for Xadago approval in US

Newron Pharma will not have to conduct any additional clinical trials for its Parkinson's disease drug Xadago in the US, setting up a new FDA filing in the coming weeks. ... Now, Newron is planning to refile a marketing application with the FDA in

Latest news

  • Rare disease therapies head the ‘class of 2015’ Rare disease therapies head the ‘class of 2015’

    maintaining the high output from pharma industry pipelines of the last few years. ... neprilysin inhibitor. Novartis. USA. safinamide. Xadago. Parkinson's disease. MAO-B inhibitor. Newron Pharma.

  • Chasing the cure for Parkinson's disease Chasing the cure for Parkinson's disease

    Generic versions of this drug combination are also available, including Parcopa (Azur Pharma). ... Currently available therapies of this class include selegiline and rasagiline. Safinamide (Newron, Zambon and Meiji Seika Pharma) is a selective and

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Newron Pharma appoints commercial affairs VP Newron Pharma appoints commercial affairs VP

    Dennis Dionne brings expertise from J&J and Novartis. Milan, Italy-based Newron Pharmaceuticals has promoted Dennis Dionne to vice president of commercial affairs. ... Stefan Weber, chief executive officer of Newron, said: “We sincerely thanks Anders

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics